Carnitine prevents cyclic GMP-induced inhibition of peroxisomal enzyme activities.
Peroxisomes, also termed as microbodies, are now known to carry out several specialized metabolic activities that are vital to cellular function. A defect in peroxisomal function leads to development of a fatal human disease, and a number of peroxisomal disorders are now linked to inherited peroxisomal enzyme abnormalities. Peroxisomal enzyme activities are also altered during pathophysiological conditions through various endogenously produced bio-molecules such as nitric oxide (NO). NO produced by cytokines or NO-donors is known to modulate peroxisomal functions, and these effects of NO are mediated through cGMP. We are reporting for the first time that L-carnitine (1-5 mm) prevents cGMP-mediated impairment of peroxisomal enzyme activities. Cyclic GMP (250-1000 muM) significantly inhibited (p < 0.01) the specific activities of catalase, acyl CoA oxidase and dihydroxyacetone-phosphate acyltransferase (DHAPATase) in human dermal fibroblasts, and treatment of cells with 1-5 mM of carnitine significantly (p < 0.001) reduced the inhibitory effects of cGMP on peroxisomal enzyme activities. These findings suggest that carnitine, previously thought to participate only in fatty acid oxidation, may in fact be regulating other cellular events including oxidative stress, and could possibly be used to correct cytokine-impaired peroxisomal functions.
Dhaunsi
Gursev S
GS
Department of Pediatrics, Faculty of Medicine, Kuwait University, Safat 13110, Kuwait. dhaunsig@hsc.kuniv.edu.kw
Al-Essa
Mazen
M
Ozand
Pinar T
PT
Moosa
Allie
A
D002331:Carnitine / Q000494:pharmacology*; D002374:Catalase / Q000037:antagonists & inhibitors / Q000378:metabolism; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000037:antagonists & inhibitors* / Q000502:physiology; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D020675:Peroxisomes / Q000201:enzymology*
D002374:Catalase; D006152:Cyclic GMP; D002331:Carnitine